University of Pennsylvania School of Medicine Jun 25 2026 Reviewed Leading CAR T cell therapy researchers have developed a human-in-the-loop artificial intelligence (AI) framework that firmly centers scientists' expertise to find viable target antigens for CAR T cell therapy. The work was led by experts from the Perelman School of Medicine at the University of Pennsylvania and Penn's Abramson Cancer Center and published today in Cell . As proof-of-concept, the team developed a CAR T targeting